Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Key Benefits of an SMSF

Olivia Long
April 2, 2020

The Bell Direct SMSF Service

Olivia Long
April 2, 2020

Morning Bell 2 April

Jessica Amir
April 2, 2020

Market Update 1 April

Jessica Amir
April 1, 2020

March Market Overview

Jessica Amir
March 31, 2020

Morning Bell 25 March

Jessica Amir
March 25, 2020

Weekly Wrap 20 March

Bell Direct
March 20, 2020

Market Update 20 March

Jessica Amir
March 20, 2020

Market Update 19 March

Jessica Amir
March 19, 2020

Morning Bell 18 March

Jessica Amir
March 18, 2020

Morning Bell 17 March

Jessica Amir
March 17, 2020